First 10 runs free

Market catalysts

Every catalyst the Opportunity Map has produced, exactly as shown in the product, with what prices did afterwards. Cards are published 24 hours after they appear in Desk.

DateCardAvg 5d

2026-09-09Vistra Drops 30% from High Amid PJM Regulatory Scrutiny and Battery OutagesVST
2026-09-09NextEra Secures $1.9B DOE Loan Guarantee for Duane Arnold Nuclear RestartVST
2026-09-09Western Digital Concludes FY2026 With $3.51B Free Cash FlowSPY-1.10%
2026-09-09Western Digital Ends FY2026 With $3.51B Free Cash Flow and $4.00 Q1 EPS OutlookSTX WDC-13.54%
2026-09-09Vertiv Projects $26B Revenue by 2030 on 20-22% Organic Data Center GrowthVRT
2026-09-09Western Digital Generates $3.51B FCF, Returns $3.1B to ShareholdersSTX WDC-13.54%
2026-09-09CRISPR Therapeutics Casgevy Sales Surge 78% QoQ to $76M Following FDA ExpansionCRSP VRTX-1.51%
2026-09-09Vertiv Targets 20% to 22% Annual Sales Growth Toward $26B Target by 2030SPY-1.10%
2026-09-09CRISPR Therapeutics Expands Casgevy Label to Pediatric Patients as Q2 Sales Hit $76MCRSP
2026-09-09Pfizer lifts full-year revenue outlook following $15.0B Q2 revenue beatPFE
2026-09-09Bitcoin Trades Down to $78,475 as Rate Pressure and Network Exploit WeighIBIT
2026-09-09NextEra Secures $1.9B DOE Loan Guarantee to Restart Iowa Nuclear FacilityGOOGL
2026-09-09Bitcoin Drops to $78,475 as Market Implied Fed Hike Probabilities Top 60%IBIT
2026-09-09Braze Delivers Q2 EPS of $0.19 on $227.23M Revenue, Beating ConsensusBRZE+4.83%
2026-09-09Rivian CFO Claire McDonough Departs for GE Vernova Leadership RoleGEV-2.73%
2026-09-09Argan Q2 Power Revenue Rises 52.9% with 22.4% Gross MarginAGX-2.09%
2026-09-09Braze Beats Q2 FY2026 Consensus With $227.23M in RevenueBRZE+4.83%
2026-09-09Lockheed Martin Upgraded to Buy at UBS on 3.2x Book-to-Bill and Missile DemandRTX-0.36%
2026-09-09Meta Connects Muse AI Agent to Personal Health Records via HealthEx IntegrationMETA+3.00%
2026-09-09Bitcoin Slides to $78,475 as Fed Rate Hike Odds Cross 60%IBIT
2026-09-09NextEra Energy Secures $1.9B DOE Loan Guarantee for Duane Arnold RestartNEE VST
2026-09-09Braze posts Q2 EPS of $0.19 and $227.2M revenue, topping consensusBRZE+4.83%
2026-09-09Liberty Latin America Director Buys $10M in Preference SharesLILA LILAK+1.04%
2026-09-09Lockheed Martin Upgraded at UBS on 3.2x Book-to-Bill and F-35 Sales GrowthSPY-1.10%
2026-09-09Rivian CFO McDonough Departs for GE Vernova Amid EV Manufacturing ShiftGEV-2.73%
2026-09-09PACS Group Agrees to Acquire Operations of 32 Florida Facilities from OHIPACS
2026-09-09NextEra Secures $1.9B DOE Loan Guarantee to Restart Iowa Nuclear FacilityGOOGL
2026-09-09Vistra Drops 30% on Battery Outages and PJM Interconnection ScrutinyVST
2026-09-09Argan Q2 Fiscal 2027 Revenue Jumps 61.5% Led by Power Segment MarginsPWR-1.23%
2026-09-09Bitcoin Pulls Back to $78,475 as Market Implied Fed Rate Hike Probability Tops 60%IBIT
2026-09-09Western Digital Concludes FY2026 With $3.51B Free Cash Flow and $500M Net CashWDC-13.54%
2026-09-09Argan Q2 Net Earnings Surge 50.4% as Power Segment Gross Margins Expand to 22.4%AGX-2.09%
2026-09-09FDA Approves Label Expansion for CRISPR Therapeutics Gene Therapy CasgevyCRSP VRTX-1.51%
2026-09-09UBS Upgrades Lockheed Martin to Buy Citing 3.2x Book-to-Bill RatioLMT+2.44%
2026-09-09Bitcoin Pulls Back to $78,475 as Market Implied Rate Hike Odds Rise Past 60%BTCUSD
2026-09-09Bitcoin Slips to $78,475 as Fed Rate Hike Probability Surpasses 60%IBIT
2026-09-09Dentsply Sirona Beats Q2 EPS at $0.52 and Reaffirms FY26 Sales OutlookXRAY-5.41%
2026-09-09CRISPR Therapeutics Casgevy Revenue Surges 78% QoQ to $76M on Pediatric LabelCRSP VRTX XBI-2.38%
2026-09-09Western Digital Concludes FY26 with $3.51B Free Cash Flow and $4.1B Q1 TargetSTX WDC-13.54%
2026-09-09Braze Reports Q2 FY26 EPS of $0.19 and Revenue of $227.23M, Topping EstimatesBRZE+4.83%
2026-09-09Braze Tops Q2 Expectations With $0.19 EPS on $227.2M RevenueBRZE+4.83%
2026-09-09Meta Integrates HealthEx Connector to Link Medical Records With Muse AI AssistantMETA+3.00%
2026-09-09Lockheed Martin Upgraded to Buy at UBS on 3.2x Book-to-Bill and Missile DemandITA-1.90%
2026-09-09HealthEx Launches Electronic Health Record Integration for Meta AI Assistant MuseMETA+3.00%
2026-09-09Argan Reports Q2 Earnings Up 50.4% as Power Gross Margin Expands to 22.4%AGX-2.09%
2026-09-09Pfizer Beats Q2 Estimates at $15B Revenue and Raises Full-Year GuidancePFE
2026-09-09Dentsply Sirona Tops Q2 EPS at $0.52 vs $0.36 Consensus and Affirms FY2026 GuidanceXRAY-5.41%
2026-09-09Bitcoin Drops to $78,475 as Fed Rate Hike Probability Pricing Tops 60%BTC-2.83%
2026-09-09Argan Reports Q2 FY27 Net Income Growth of 50% on Power Segment StrengthAGX-2.09%
2026-09-09NextEra Secures $1.9B DOE Loan Guarantee to Restart Iowa Nuclear FacilitySPY-1.10%

← Newer Older →

Find trades for this development

Screen tradable expressions of this catalyst against your horizon and constraints. Nothing is submitted without your review.

First 10 runs free

See today's live cards

Public pages are published 24 hours after the product shows them. The product shows every catalyst, event and causal reading as it happens, mapped to your holdings.

Open live cards